av/innate-pharma-sa--big.svg

NASDAQ:IPHA

Innate Pharma S.A.

  • Stock

USD

Last Close

1.93

02/05 08:31

Market Cap

163.52M

Beta: 0.32

Volume Today

18.96K

Avg: 17.77K

PE Ratio

−1.87

PFCF: −9.30

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
net income
-11.86M
-
-23.72M
100%
-14.54M
38.68%
-21.76M
49.60%
3.15M
114.48%
6.38M
102.32%
-32.20M
605.07%
-64.35M
99.82%
859K
101.33%
1.72M
100%
-4.64M
370.31%
-9.29M
100%
-12.38M
33.31%
-24.76M
100%
depreciation and amortization
1.08M
-
2.19M
102.21%
1.21M
44.62%
2.38M
95.80%
1.01M
57.30%
2.04M
101.18%
1.19M
41.85%
2.38M
100.59%
1.82M
23.49%
3.65M
100%
723K
80.16%
1.45M
100%
571K
60.51%
1.15M
100.70%
deferred income tax
-28.58M
-
-5.37M
81.21%
5.74M
206.89%
1.30M
77.35%
-15.91M
1,323.96%
stock based compensation
426.50K
-
426.50K
0%
882K
106.80%
882K
0%
1.30M
47.17%
1.30M
0%
826.50K
36.33%
826.50K
0%
700.50K
15.25%
700.50K
0%
1.43M
103.78%
853K
-
change in working capital
2.88M
-
-12.64M
538.74%
-4.32M
65.82%
2.75M
163.76%
9.71M
252.49%
-10.98M
213.07%
4.54M
141.39%
-1.53M
133.59%
-2.00M
31.09%
-18.53M
826.27%
-6.52M
64.79%
-13.56M
107.88%
15.65M
215.44%
26.60M
69.89%
accounts receivables
3.26M
-
6.51M
100%
-1.56M
123.95%
-3.12M
100%
-6.64M
112.98%
-13.29M
100%
4.54M
134.18%
9.09M
100%
-2.00M
122.02%
-4.00M
100%
-4.83M
20.78%
15.92M
-
31.84M
100%
inventory
accounts payables
-12.49M
-
11.55M
-
-9.91M
-
2.24M
-
-3.92M
-
-1.15M
-
other working capital
-376.50K
-
-6.66M
1,668.66%
-2.76M
58.56%
-5.67M
105.58%
16.35M
388.25%
12.22M
25.27%
-12.86M
-
-10.61M
-
-1.69M
84.06%
-264K
-
-4.10M
1,451.52%
other non cash items
-8.11M
-
13.29M
263.85%
3.12M
76.52%
-14.21M
555.33%
-14.56M
2.48%
30.89M
312.09%
20.83M
32.56%
36.72M
76.30%
-8.41M
122.91%
16.91M
301.01%
-1.53M
109.04%
310K
120.27%
-3.18M
1,125.48%
57K
101.79%
net cash provided by operating activities
-15.58M
-
-31.24M
100.47%
-13.65M
56.31%
-27.17M
99.05%
609K
102.24%
1.05M
72.25%
-10.19M
1,071.02%
-20.20M
98.34%
-5.73M
71.63%
-11.46M
100%
-10.55M
8.01%
-21.09M
100%
1.52M
107.20%
3.04M
100%
investments in property plant and equipment
-120K
-
-336K
180%
-344.50K
2.53%
-995K
188.82%
-210K
78.89%
-421K
100.48%
-57.50K
86.34%
-702K
1,120.87%
-154.50K
77.99%
-312K
101.94%
-21K
93.27%
-2.04M
9,623.80%
-141.50K
93.07%
-283K
100%
acquisitions net
2K
-
5K
-
150K
-
purchases of investments
sales maturities of investments
3M
-
22.77M
-
1.22M
-
other investing activites
-3.50K
-
-3.50K
0%
9.50K
371.43%
40K
321.05%
12.50K
68.75%
1K
92%
1.19M
119,250%
-1K
100.08%
31.50K
3,250%
66K
109.52%
10.46M
15,747.73%
999
99.99%
607.50K
60,710.81%
net cash used for investing activites
-123.50K
-
-333K
169.64%
-335K
0.60%
-951K
183.88%
-197.50K
79.23%
-420K
112.66%
1.14M
370.48%
2.30M
102.20%
-123K
105.35%
-246K
100%
10.44M
4,343.29%
20.88M
100%
466K
97.77%
932K
100%
debt repayment
-1.13M
-
-27.76M
-
-958K
-
-1.07M
-
-1.59M
-
-767K
-
-4.42M
-
common stock issued
61K
-
438K
-
192K
-
6K
-
348K
-
47K
-
93K
-
common stock repurchased
dividends paid
other financing activites
-613K
-
-613K
0%
14.02M
2,387.44%
14.02M
0.01%
-480K
103.42%
-480K
0%
-434K
9.58%
-623K
-
-360K
-
-2.16M
-
net cash used provided by financing activities
-613K
-
-1.07M
73.90%
14.02M
1,415.38%
28.20M
101.08%
-480K
101.70%
-766K
59.58%
-434K
43.34%
-1.06M
144.70%
-623K
41.34%
-1.25M
100%
-360K
71.11%
-720K
100%
-2.16M
200.49%
-4.33M
100%
effect of forex changes on cash
-89K
-
-89K
0%
-152.50K
71.35%
-152.50K
0%
-335K
119.67%
-335K
0%
121K
136.12%
121K
0%
72.50K
40.08%
72.50K
0%
64.50K
11.03%
-128.50K
-
net change in cash
-16.41M
-
-32.81M
99.99%
-113K
99.66%
-224K
98.23%
-403.50K
80.13%
-807K
100%
-9.36M
1,060.22%
-18.72M
99.98%
-6.41M
65.79%
-12.81M
99.98%
-403.50K
96.85%
-809K
100.50%
-308K
61.93%
-615K
99.68%
cash at beginning of period
136.79M
-
103.98M
23.99%
103.98M
0%
103.76M
0.22%
103.76M
0%
102.95M
0.78%
102.95M
0%
84.22M
-
71.41M
-
70.61M
-
cash at end of period
-16.41M
-
103.98M
733.77%
103.87M
0.11%
103.76M
0.11%
103.35M
0.39%
102.95M
0.39%
93.59M
9.09%
84.22M
10.00%
-6.41M
107.61%
71.41M
1,214.80%
-403.50K
100.57%
70.61M
17,598.14%
-308K
100.44%
69.99M
22,824.03%
operating cash flow
-15.58M
-
-31.24M
100.47%
-13.65M
56.31%
-27.17M
99.05%
609K
102.24%
1.05M
72.25%
-10.19M
1,071.02%
-20.20M
98.34%
-5.73M
71.63%
-11.46M
100%
-10.55M
8.01%
-21.09M
100%
1.52M
107.20%
3.04M
100%
capital expenditure
-120K
-
-336K
180%
-344.50K
2.53%
-995K
188.82%
-210K
78.89%
-421K
100.48%
-57.50K
86.34%
-702K
1,120.87%
-154.50K
77.99%
-312K
101.94%
-21K
93.27%
-2.04M
9,623.80%
-141.50K
93.07%
-283K
100%
free cash flow
-15.70M
-
-31.57M
101.08%
-13.99M
55.68%
-28.16M
101.27%
399K
101.42%
628K
57.39%
-10.24M
1,731.13%
-20.91M
104.08%
-5.89M
71.84%
-11.78M
100.05%
-10.57M
10.27%
-23.13M
118.93%
1.38M
105.95%
2.75M
100%

All numbers in USD (except ratios and percentages)